SCHEMBL6986189

SCHEMBL6986189

O=C1CC[C@H]([C@H]2c3ccccc3C=CN2C(=O)OCc2ccccc2)O1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX4 Q99571 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CYP2C19 P33261 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
F2 P00734 2/20 0.39
ELANE P08246 2/20 0.39
CTSG P08311 1/20 0.39
PSEN1 P49768 2/20 0.38
PSEN2 P49810 2/20 0.38
APH1B Q8WW43 2/20 0.38
NCSTN Q92542 2/20 0.38
APH1A Q96BI3 2/20 0.38
PSENEN Q9NZ42 2/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6986196 1.00 P2RX4 (0.40) P2RX4SMN1; SMN2CYP2C19NPC1RAB9A
SCHEMBL6991071 0.76 PARP1 (0.48) SMN1; SMN2NPC1RAB9AF2ELANE
SCHEMBL29380426 0.76 PARP1 (0.48) SMN1; SMN2NPC1RAB9AF2ELANE
SCHEMBL7566815 0.76 PARP1 (0.48) SMN1; SMN2NPC1RAB9AF2ELANE
SCHEMBL6991074 0.76 PARP1 (0.48) SMN1; SMN2NPC1RAB9AF2ELANE
SCHEMBL7566816 0.76 PARP1 (0.48) SMN1; SMN2NPC1RAB9AF2ELANE
SCHEMBL6230309 0.70 P2RX4 (0.45) P2RX4SMN1; SMN2CYP2C19NPC1RAB9A
SCHEMBL6989538 0.69 MTNR1B (0.49) SMN1; SMN2NPC1RAB9ANPSR1ALDH1A1
SCHEMBL6989536 0.69 MTNR1B (0.49) SMN1; SMN2NPC1RAB9ANPSR1ALDH1A1
SCHEMBL1526556 0.67 HTR2C (0.46) SMN1; SMN2NPC1RAB9AF2ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6649626-B1 Stimulants of gamma -aminobutyric acid receptors; psychological disorders CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2003-11-18 US disclosed
EP-1224182-B1 N-SUBSTITUTED 1-(BUTYROLACTONE)-ISOQUINOLINES FOR TREATING NERVOUS DISORDERS CENTRE NAT RECH SCIENT (FR) 2003-07-16 EP disclosed